FDA Warning Letter — Abon Biopharm (Hangzhou) Co., Ltd.
The FDA took a Warning Letter action against Abon Biopharm (Hangzhou) Co., Ltd. on Dec 22, 2010 (Hangzhou, China). The action was issued by CDRH and concerns devices products. This facility has 3 recent FDA inspections on record.
Action Details
- Facility
- Abon Biopharm (Hangzhou) Co., Ltd.
- Date
- Dec 22, 2010
- Fiscal Year
- 2011
- Product Type
- Devices
- Center
- CDRH
- Location
- Hangzhou (China)